comparemela.com

Latest Breaking News On - Syneos health trading - Page 1 : comparemela.com

Syneos Health (NASDAQ:SYNH) Sees Large Volume Increase

Syneos Health, Inc. (NASDAQ:SYNH – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 621,618 shares traded hands during trading, a decline of 67% from the previous session’s volume of 1,885,298 shares.The stock last traded at $42.98 and had previously closed at $42.97. Wall Street Analyst Weigh In Separately, StockNews.com started coverage on […]

Syneos Health (NASDAQ:SYNH) Coverage Initiated at StockNews com

Research analysts at StockNews.com initiated coverage on shares of Syneos Health (NASDAQ:SYNH – Get Rating) in a report released on Saturday. The firm set a “hold” rating on the stock. SYNH has been the subject of several other research reports. JPMorgan Chase & Co. raised Syneos Health from an “underweight” rating to a “neutral” rating […]

StockNews com Initiates Coverage on Syneos Health (NASDAQ:SYNH)

StockNews.com started coverage on shares of Syneos Health (NASDAQ:SYNH – Get Rating) in a report released on Friday. The brokerage issued a hold rating on the stock. Several other equities research analysts have also issued reports on the stock. Robert W. Baird lowered shares of Syneos Health from an outperform rating to a neutral rating […]

Zacks Research Comments on Syneos Health, Inc s FY2025 Earnings (NASDAQ:SYNH)

Syneos Health, Inc. (NASDAQ:SYNH – Get Rating) – Equities researchers at Zacks Research decreased their FY2025 earnings per share (EPS) estimates for shares of Syneos Health in a report released on Tuesday, April 25th. Zacks Research analyst R. Anand now expects that the company will earn $3.23 per share for the year, down from their […]

Syneos Health (NASDAQ:SYNH) Price Target Cut to $37 00 by Analysts at Barclays

Syneos Health (NASDAQ:SYNH – Get Rating) had its price target cut by research analysts at Barclays from $45.00 to $37.00 in a note issued to investors on Tuesday, The Fly reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 5.93% from the company’s previous […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.